Overview

Sedative Effects in Obstructive Sleep Apnea

Status:
Withdrawn

Trial end date:
2015-11-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to determine the effect of dexmedetomidine infusion on the Apnea / Hypopnea Index (AHI) of individuals with previously documented obstructive sleep apnea. We hypothesize that dexmedetomidine infusion may reduce the AHI in patients with obstructive sleep apnea (OSA).

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Duke University

Treatments:

Dexmedetomidine